
A healthcare marketing strategy that starts with a job posting is already backwards.
Before a medtech founder hires anyone, the management team has to know what it takes to go from first contact to closed revenue. Nobody can hire for a process nobody on the team has run.
Key Takeaways
Watch the full episode on YouTube
Most medtech founders build a healthcare marketing strategy around the assumption that hiring solves the go-to-market problem. It doesn't, and the mistake is expensive.
I interviewed Bruce Cleveland on an episode about product-market fit, category design, and why startups waste funding. He's advised medtech and enterprise founders on go-to-market for two decades, and his rule is specific:
"The management team should know what it takes to go from contact to cash. If the management team doesn't know that, if the CEO, the founders don't know that, how do you hire a salesperson?"
That's not a metaphor. Cleveland means the CEO, the head of engineering, the head of marketing, and the head of sales should personally sell the first 10 customers before anyone delegates that process to a hire.
The reason is direct. A management team that has never sold anything can't write a job description for someone who will, and can't evaluate whether that hire is doing the job right once they start.
Skipping this step is where Cleveland sees the most capital burned. A venture team pushes a founder to hire a sales function before the founding team has run the experiment themselves.
The company then spends its most expensive capital finding out the hard way what it should have already known.
A healthcare marketing strategy assumes a market exists to sell into. In medtech, that assumption is usually wrong at the exact moment a founder is ready to hire a marketing team.
I covered this on an episode recorded shortly after interviewing Fazila Seker of Insight Medbotics:
"Markets don't form after launch. They form before it. And in medtech, they don't just form on their own. They have to be crafted and engineered. Nobody finds you in medtech. You engineer being found."
Founders who clear FDA and still hear "come back when you have more traction" almost always read that as a fundraising problem or a sales problem. It isn't. It's a market problem, and no amount of hiring fixes it.
The founders behind roughly $17 billion to $20 billion in medtech exits, including Axonics, NuVasive, and Prometheus Biosciences, all described the same pattern in their own words.
The deal never closed in the deal room. The market was shaped years before anyone sat down to negotiate.
If hiring isn't the first move, something has to come before it. That something is category design, and most founders skip straight past it toward execution.
I covered this on an episode about how market engineering helps medtech startups raise capital:
"What matters is defining the category or redesigning one, aligning your messaging so people understand you, building the narrative, and then you drive demand with your go-to-market."
Founders default to a different order: engineer the product, get FDA clearance, hire sales, run marketing. That sequence treats category, messaging, and narrative as afterthoughts instead of prerequisites.
There are medtech companies that have raised over a billion dollars in funding with nothing to show for it, because they never defined or redesigned their category against the incumbent already occupying it.
The market compares any newcomer to the category leader by default, and an undefined newcomer loses every time.
Category clarity isn't optional groundwork. It's the thing that determines whether the healthcare marketing strategy built on top of it has anything real to execute against.
Even once category and narrative work is underway, the timing question remains: when does a founder bring someone on staff?
Gene Nagel, who runs medical device sales training programs, gave the answer on an episode about fixing medical sales training:
"Before you hire somebody full-time and you assign equity and benefits, all these different things. You hire somebody, you commit equity, all these things, and they're just not the right person, and you lose a year."
Nagel's recommendation applies directly to healthcare marketing strategy: consultants and agencies exist to lay the foundation before a founder commits equity to someone who turns out to be the wrong fit.
An agency has set up campaigns far more times than even the strongest individual hire a founder could find. That repetition is exactly what a pre-traction medtech company needs before it's ready to build and manage an internal team.
In my experience working with medtech founders, the ones who get this backward aren't careless. They're following the sequence that looks efficient on paper: clear FDA, raise money, hire the team, launch.
That sequence works when a market already exists and simply needs capturing. It doesn't work when the category itself still has to be built, which is true for most genuinely new medtech.
The founders who get this right sell the first customers themselves, define the category before assuming one exists, and bring in outside help to build the foundation before committing to a full-time hire. Hiring comes last in that sequence, not first.
Define the category, align messaging, and build market narrative before hiring anyone. Founders should also personally sell the first customers themselves so they understand what a hire is being asked to do.
Companies waste capital when the founding team hires a salesperson or marketer before understanding the sales process themselves. Without that experience, they can't evaluate whether the hire is executing correctly or is simply the wrong person for a role nobody has defined.
Yes. An agency or consultant lays the commercial foundation without the cost of committing equity and benefits to someone who might not be the right fit. Founders can use that period to validate the category and process before making a permanent hire.
If you're doing this yourself. Read the medtech commercialization strategy breakdown to see the full sequence a healthcare marketing strategy has to follow before any hiring decision makes sense.
If you want it engineered with you. MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. For founders about to make a first sales or marketing hire, the audit checks whether the category exists yet for that hire to sell into.
Subscribe wherever you listen to podcasts.
Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry. He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.